|
Delayed
Nasdaq Stockholm
09:25:46 02/11/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 1.740 SEK | -0.85% |
|
0.00% | -15.94% |
| 14/10 | Axichem Bags SEK1 Million Order for Dietary Supplements Ingredient in US | MT |
| 27/08 | AXichem AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Company Valuation: aXichem AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 779 | 406.8 | 229 | 86.2 | 80.1 | 122.4 |
| Change | - | -47.78% | -43.7% | -62.36% | -7.08% | 52.77% |
| Enterprise Value (EV) 1 | 767 | 397.3 | 241.2 | 92.16 | 65.74 | 124 |
| Change | - | -48.2% | -39.29% | -61.8% | -28.67% | 88.64% |
| P/E | -57.6x | -26.6x | -13.3x | -3.89x | -2.93x | -6.9x |
| PBR | 14.5x | 7.23x | 5.68x | 1.78x | 1.14x | 2.32x |
| PEG | - | -2.98x | -1x | 2.98x | 0.1x | 0.2x |
| Capitalization / Revenue | 635x | 93.3x | 45.7x | 47.7x | 9.35x | 6.63x |
| EV / Revenue | 625x | 91.1x | 48.2x | 50.9x | 7.67x | 6.72x |
| EV / EBITDA | -63.9x | -29.4x | -19.4x | -6.1x | -4.88x | -8.26x |
| EV / EBIT | -56.8x | -26.4x | -16.6x | -5.32x | -4.15x | -7.09x |
| EV / FCF | -55.3x | -27x | -14.7x | -6.17x | -5.29x | -12.7x |
| FCF Yield | -1.81% | -3.7% | -6.82% | -16.2% | -18.9% | -7.84% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.8483 | -0.924 | -1.044 | -1.03 | -0.4623 | -0.3 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1.227 | 4.362 | 5.007 | 1.809 | 8.57 | 18.45 |
| EBITDA 1 | -12.01 | -13.51 | -12.44 | -15.1 | -13.48 | -15.02 |
| EBIT 1 | -13.51 | -15.07 | -14.54 | -17.32 | -15.83 | -17.49 |
| Net income 1 | -13.51 | -15.09 | -17.26 | -20.81 | -17.81 | -17.63 |
| Net Debt 1 | -12.04 | -9.454 | 12.21 | 5.959 | -14.36 | 1.644 |
| Reference price 2 | 48.900 | 24.600 | 13.850 | 4.010 | 1.355 | 2.070 |
| Nbr of stocks (in thousands) | 15,931 | 16,536 | 16,536 | 21,496 | 59,115 | 59,115 |
| Announcement Date | 7/5/21 | 10/5/22 | 26/5/23 | 29/5/24 | 28/5/25 | 10/6/26 |
1SEK in Million2SEK
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 12.1M | |
| 40.09x | 5.41x | 21.97x | 0.96% | 84.98B | |
| 34.4x | 5.19x | 22.18x | 1.86% | 44.52B | |
| 24.33x | 2.88x | 15.07x | 2.15% | 34.88B | |
| 15.57x | 1.61x | 9.03x | 2.67% | 34.16B | |
| 39.22x | 7.05x | 18.7x | 1.58% | 32.15B | |
| 14.93x | 1.42x | 8.79x | 2.14% | 26.59B | |
| 39.32x | 9.52x | 29.22x | 2.26% | 23.93B | |
| 26.29x | 2.83x | 11.52x | 1.71% | 18.91B | |
| 7.39x | 2.14x | 4.25x | 3.53% | 15.61B | |
| Average | 26.84x | 4.23x | 15.64x | 2.1% | 31.57B | |
| Weighted average by Cap. | 30.18x | 4.51x | 17.44x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AXIC A Stock
- Valuation aXichem AB
Select your edition
All financial news and data tailored to specific country editions
